Clinical Trial Update: Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating two versus three doses of an HPV vaccine in India for cervical cancer and precancerous lesions; status active not recruiting with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Precancerous Lesions

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Partha Basu | Conditions: Cervical Cancer, Cervical Precancerous Lesions | Phase 4 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-10-20